Skip To Main Content

Artikler

Sorter etter

Filter

Nullstille
  • Terapiområde

Efficacy and safety of dupilumab in patients with PN with or without a history of atopic comorbidities

EFLUELDA - Høydosevaksine mot sesonginfluensa

FLUNITY-HD : the largest individually randomised influenza vaccine effectiveness study of its kind.

FLUNITY-HD is the largest individually randomised influenza vaccine effectiveness study, with nearly half a million older adults across multiple seasons.1

Cumulative Life Course Impairment (CLCI) in Atopic Dermatitis

Why Choose Toujeo® (Insulin Glargine)

BRIGHT publication

The Bright study demonstrated similar efficacy and safety of Toujeo® (Glargine 300) compared to degludec (insulin degludec) in type 2 diabetes patients who had not previously received basal insulin1.

Understanding Gaucher Disease: Symptoms, Classification, and Clinical Presentation

Gaucher disease is a lysosomal storage disorder caused by a pathogenic variant in the gene responsible for producing the enzyme acid β-glucosidase. More than 300 alleles carrying pathogenic variants have already been identified.1

The story of the Beta Cells and their role in autoimmune Type 1 Diabetes

Diagnostic and confirmation testing

Gaucher disease is rare and has signs and symptoms that can be confused with those of many other diseases. However, some tests allow the definitive diagnosis of the disease.

Understanding Gaucher Disease: Genetics, Transmission, and Family Screening

Diagnostic Algorithm

Defining ITP

Low platelet counts are one facet of ITP, but when we look at it from another angle, we see the multiple dimensions of ITP. ITP is a condition of complex immune dysregulation that reduces platelet counts—causing bleeding, bruising, fatigue, and other health-related quality-of-life (HRQoL) issues—while increasing inflammation and the risk of thromboembolic events (TEs).1-5